Literature DB >> 8822894

Evolutionary origins of Microsporidia and basis for benzimidazole sensitivity: an update.

T Edlind1, S Katiyar, G Visvesvara, J Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8822894     DOI： 10.1111/j.1550-7408.1996.tb05029.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN： 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  7 in total

1.  Analysis of the beta-tubulin gene from Vittaforma corneae suggests benzimidazole resistance.

Authors:  Caspar Franzen; Bernd Salzberger
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

2.  In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.

Authors:  O Ridoux; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 3.  Microsporidia: Obligate Intracellular Pathogens Within the Fungal Kingdom.

Authors:  Bing Han; Louis M Weiss
Journal:  Microbiol Spectr       Date:  2017-04

4.  Effects of albendazole, fumagillin, and TNP-470 on microsporidial replication in vitro.

Authors:  E S Didier
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

Review 5.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

6.  Analysis of the beta-tubulin gene and morphological changes of the microsporidium Anncaliia algerae both suggest albendazole sensitivity.

Authors:  Marianita Santiana; Cyrilla Pau; Peter M Takvorian; Ann Cali
Journal:  J Eukaryot Microbiol       Date:  2014-09-15       Impact factor: 3.346

Review 7.  Therapeutic targets for the treatment of microsporidiosis in humans.

Authors:  Bing Han; Louis M Weiss
Journal:  Expert Opin Ther Targets       Date:  2018-11-01       Impact factor: 6.902
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.